MassDevice.com +3 | The top 3 med-tech stories for February 7, 2013
February 7, 2013 by MassDevice staff
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
St. Jude's Durata defibrillator 'immune' to Riata flaws?
St. Jude Medical's Durata implantable cardiac defibrillator leads should be "relatively immune...
Weight loss: GI Dynamics adds centers in Europe
GI Dynamics says another 5 centers in Europe are offering its EndoBarrier weight-loss device for...
Boston Scientific launches U.S. Parkinson's trial, cites interim EU data
Boston Scientific launches a U.S. clinical trial of its Vercise deep-brain stimulation treatment for...
Yale study of Medtronic's Infuse shows it's equivalent to bone graft, but studies were biased
A pair of independent analyses of patient-level data commissioned by a Yale University open data...
